EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inversion-recovery ultrashort-echo-time (IR-UTE) MRI-based detection of radiation dose heterogeneity in gynecologic cancer patients treated with HDR brachytherapy

Khadija Sheikh, Bruce L Daniel, Michael Roumeliotis, Junghoon Lee, William T Hrinivich, Thomas Benkert, Himanshu Bhat, Ravi T Seethamraju, Akila N Viswanathan, Ehud J Schmidt

Radiation Oncology · 2024

DOI: 10.1186/s13014-024-02499-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiation Oncology, 2024. Verfasst von Khadija Sheikh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Johns Hopkins University School of Medicine, 5255 Loughboro Road NW, Washington, DC, USA. ksheikh4@jhmi.edu. Hauptthemen laut MEDLINE: Brachytherapy, Magnetic Resonance Imaging, Genital Neoplasms, Female, Radiotherapy Dosage. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the relationship between delivered radiation (RT) and post-RT inversion-recovery ultrashort-echo-time (IR-UTE) MRI signal-intensity (SI) in gynecologic cancer patients treated with high-dose-rate (HDR) brachytherapy (BT).

Methods

Seven patients underwent whole-pelvis RT (WPRT) followed by BT to the high-risk clinical target volume (HR-CTV). MR images were acquired at three time-points; pre-RT, post-WPRT/pre-BT, and 3–6 months post-BT. Diffuse-fibrosis (F Diffuse ) was imaged with a non-contrast dual-echo IR (inversion time [TI] = 60 ms) UTE research application, with image-subtraction of the later echo, only retaining the ultrashort-echo SI. Dense-fibrosis (F Dense ) imaging utilized single-echo Late-Gadolinium-Enhanced IR-UTE, acquired ∼ 15 min post-Gadavist injection. Resulting F Diffuse and F Dense SI were normalized to the corresponding gluteal-muscle SI. Images were deformably registered between time-points based on normal tissue anatomy. The remnant tumor at both time-points was segmented using multi-parametric MRI. Contours corresponding to the 50%, 100%, 150%, and 200% isodose lines (IDLs) of the prescription BT-dose were created. Mean F Diffuse and F Dense SI within (i) each IDL contour and (ii) the remnant tumor were calculated. Post-BT F Diffuse and F Dense SI were correlated with prescribed BT-dose. To determine the relationship between BT-dose and IR-UTE SI, the differences in the post-BT F Dense across IDLs was determined using paired t-tests with Bonferroni correction.

Results

F Dense was higher in regions of higher dose for 6/7 patients, with mean ± SD values of 357 ± 103% and 331 ± 97% ( p = .03) in the 100% and 50% IDL, respectively. F Dense was higher in regions of higher dose in the responsive regions with mean ± SD values of 380 ± 122% and 356 ± 135% ( p = .03) in the 150% and 50% IDL, respectively. Within the segmented remnant tumor, an increase in prescribed dose correlated with an increase in F Dense post-BT ( n = 5, r = .89, p = .04). Post-BT F Diffuse inversely correlated ( n = 7, r = -.83, p = .02) with prescribed BT-dose within the 100% IDL.

Conclusions

Results suggest that F Dense SI 3–6 months post-BT is a sensitive measure of tissue response to heterogeneous BT radiation-dose. Future studies will validate whether F Diffuse and F Dense are accurate biomarkers of fibrotic radiation response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyMagnetic Resonance ImagingGenital Neoplasms, FemaleRadiotherapy DosageHumansFemaleMiddle AgedAgedRadiotherapy Planning, Computer-Assisted

Autor:innen und Institutionen

  • Department of Radiation Oncology, Johns Hopkins University School of Medicine, 5255 Loughboro Road NW, Washington, DC, USA. ksheikh4@jhmi.edu.
  • Department of Radiology, Stanford University, Stanford, CA, USA.
  • Department of Radiation Oncology, Johns Hopkins University School of Medicine, 5255 Loughboro Road NW, Washington, DC, USA.
  • MR Application Predevelopment, Siemens Healthineers AG, Erlangen, Germany.
  • Siemens Healthineers, Boston, MA, USA.
  • Department of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Sheikh, K., Daniel, B. L., Roumeliotis, M., Lee, J., Hrinivich, W. T., Benkert, T., Bhat, H., Seethamraju, R. T., Viswanathan, A. N., & Schmidt, E. J. (2024). Inversion-recovery ultrashort-echo-time (IR-UTE) MRI-based detection of radiation dose heterogeneity in gynecologic cancer patients treated with HDR brachytherapy. Radiation Oncology. https://doi.org/10.1186/s13014-024-02499-2

Vancouver

Sheikh K, Daniel BL, Roumeliotis M, Lee J, Hrinivich WT, Benkert T, et al. Inversion-recovery ultrashort-echo-time (IR-UTE) MRI-based detection of radiation dose heterogeneity in gynecologic cancer patients treated with HDR brachytherapy. Radiation Oncology. 2024. doi:10.1186/s13014-024-02499-2

BibTeX
@article{Sheikh2024,
  author = {Sheikh, Khadija and Daniel, Bruce L and Roumeliotis, Michael and Lee, Junghoon and Hrinivich, William T and Benkert, Thomas and Bhat, Himanshu and Seethamraju, Ravi T and Viswanathan, Akila N and Schmidt, Ehud J},
  title = {Inversion-recovery ultrashort-echo-time (IR-UTE) MRI-based detection of radiation dose heterogeneity in gynecologic cancer patients treated with HDR brachytherapy},
  journal = {Radiation Oncology},
  year = {2024},
  doi = {10.1186/s13014-024-02499-2}
}
Kostenlos starten →